Literature DB >> 30835038

Wnt Antagonists in Hematopoietic and Immune Cell Fate: Implications for Osteoporosis Therapies.

Betsabel Chicana1, Cristine Donham1, Alberto J Millan1, Jennifer O Manilay2,3.   

Abstract

PURPOSE OF REVIEW: We reviewed the current literature on the roles of the Wnt antagonists sclerostin (Sost) and sclerostin-containing domain protein 1 (Sostdc1) on bone homeostasis, the relationship of the hypoxia-inducible factor (Hif) and von Hippel-Lindau (Vhl) pathways on Sost expression, and how changes in bone induced by depletion of Sost, Sostdc1, and Vhl affect hematopoietic cells. RECENT
FINDINGS: B cell development is adversely affected in Sost-knockout mice and is more severely affected in Vhl-knockout mice. Inflammation in the Sost-/- bone microenvironment could alter hematopoietic stem cell behavior. Sostdc1-/- mice display defects in natural killer cell development and cytotoxicity. Depletion of Sost and Sostdc1 have effects on immune cell function that warrant investigation in patients receiving Wnt antagonist-depleting therapies for treatment of bone diseases. Additional clinical applications for manipulation of Wnt antagonists include cancer immunotherapies, stem cell transplantation, and directed differentiation to immune lineages.

Entities:  

Keywords:  Cell differentiation; Hematopoiesis; Immunology; Osteoimmunology; Wnt; Wnt antagonists

Mesh:

Substances:

Year:  2019        PMID: 30835038      PMCID: PMC6715281          DOI: 10.1007/s11914-019-00503-3

Source DB:  PubMed          Journal:  Curr Osteoporos Rep        ISSN: 1544-1873            Impact factor:   5.096


  95 in total

1.  Inhibition of Wnt signaling by Wise (Sostdc1) and negative feedback from Shh controls tooth number and patterning.

Authors:  Youngwook Ahn; Brian W Sanderson; Ophir D Klein; Robb Krumlauf
Journal:  Development       Date:  2010-08-19       Impact factor: 6.868

2.  Noncanonical Wnt signaling maintains hematopoietic stem cells in the niche.

Authors:  Ryohichi Sugimura; Xi C He; Aparna Venkatraman; Fumio Arai; Andrew Box; Craig Semerad; Jeffrey S Haug; Lai Peng; Xiao-Bo Zhong; Toshio Suda; Linheng Li
Journal:  Cell       Date:  2012-07-20       Impact factor: 41.582

3.  Van Buchem's Disease.

Authors:  Kawtar Nassar; Wafae Rachidi; Saadia Janani; Ouafa Mkinsi
Journal:  Joint Bone Spine       Date:  2016-03-08       Impact factor: 4.929

Review 4.  Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy.

Authors:  Gregg L Semenza
Journal:  Trends Pharmacol Sci       Date:  2012-03-06       Impact factor: 14.819

Review 5.  MANAGEMENT OF ENDOCRINE DISEASE: Novel anabolic treatments for osteoporosis.

Authors:  Ernesto Canalis
Journal:  Eur J Endocrinol       Date:  2017-11-07       Impact factor: 6.664

6.  Up-regulation of glycolytic metabolism is required for HIF1α-driven bone formation.

Authors:  Jenna N Regan; Joohyun Lim; Yu Shi; Kyu Sang Joeng; Jeffrey M Arbeit; Ralph V Shohet; Fanxin Long
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-27       Impact factor: 11.205

7.  Identification of a secreted BMP antagonist, ectodin, integrating BMP, FGF, and SHH signals from the tooth enamel knot.

Authors:  Johanna Laurikkala; Yoshiaki Kassai; Leila Pakkasjärvi; Irma Thesleff; Nobuyuki Itoh
Journal:  Dev Biol       Date:  2003-12-01       Impact factor: 3.582

8.  The hypoxia-inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal development.

Authors:  Ying Wang; Chao Wan; Lianfu Deng; Ximeng Liu; Xuemei Cao; Shawn R Gilbert; Mary L Bouxsein; Marie-Claude Faugere; Robert E Guldberg; Louis C Gerstenfeld; Volker H Haase; Randall S Johnson; Ernestina Schipani; Thomas L Clemens
Journal:  J Clin Invest       Date:  2007-06       Impact factor: 14.808

9.  O2 regulates stem cells through Wnt/β-catenin signalling.

Authors:  Jolly Mazumdar; W Timothy O'Brien; Randall S Johnson; Joseph C LaManna; Juan C Chavez; Peter S Klein; M Celeste Simon
Journal:  Nat Cell Biol       Date:  2010-09-19       Impact factor: 28.824

10.  Adenomatous polyposis coli and hypoxia-inducible factor-1{alpha} have an antagonistic connection.

Authors:  Ian P Newton; Niall S Kenneth; Paul L Appleton; Inke Näthke; Sonia Rocha
Journal:  Mol Biol Cell       Date:  2010-09-15       Impact factor: 4.138

View more
  2 in total

Review 1.  Uterine Sensitization-Associated Gene-1 in the Progression of Kidney Diseases.

Authors:  Xiaohu Li; Wenlong Yue; Guiwen Feng; Jinfeng Li
Journal:  J Immunol Res       Date:  2021-08-07       Impact factor: 4.818

2.  The Wnt pathway regulator expression levels and their relationship to bone metabolism in thoracolumbar osteoporotic vertebral compression fracture patients.

Authors:  Xuefeng Ma; Xiaoqi Zhu; Xu He; Xiaobo Yi; Anmin Jin
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.